Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Simon Property Group Inc (SPG) vs Twist Bioscience Corp (TWST) Price & Performance

Simon Property Group IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Simon Property Group Inc vs Twist Bioscience Corp — how do they compare? Simon Property Group Inc trades at $227 (market cap $74.00B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Simon Property Group Inc is far larger — about 13.6× Twist Bioscience Corp's market cap, and Simon Property Group Inc pays a 3.86% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

SPGTWST
Market Cap
$74.00B$5.45B
Sector
Real EstateHealth
52-Week High
$228.70$102.88
52-Week Low
$160.68$24.16
Enterprise Value
$102.48B$5.37B
Dividend Yield
3.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Simon Property Group Inc

Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.

Read more on SPG

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST